Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility ...

Former Giants quarterback and two-time Super Bowl champion Eli Manning is among the group of first-time nominees for the Pro Football Hall of Fame class of 2025. Manning led the Giants to Super ...

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly said the Food and Drug Administration approved its treatment for moderate-to-severe eczema that isn't well controlled despite treatment with topical prescription therapies. The treatment ...

Peyton and Eli Manning could not believe Saquon Barkley dropped that ball. The Eagles led the Falcons 18-15 with 1:45 remaining in the fourth quarter of their “Monday Night Football” matchup ...

Eli Lilly has ben able to increase its manufacturing capacity to meet demand for its GLP-1 drugs. The company hopes this will reduce competition from drug compounding businesses. The stock looks ...

Eli Manning, the legendary Giants quarterback who's also part of the football success of the Mannings, recently poked some fun at Arch's starting debut for Texas and how it stacks up against the ...

the West Virginia Mountaineers had a number of important key plays, with most from young, redshirt freshman quarterback Eli Holstein. The Panthers were down 34-24 with 4:55 remaining and home fans ...

ALCOA — Alcoa football’s Eli Graf looked to throw the ball to Eli Owens on the 5-yard pass toward the right sideline. It was fourth-and-3 on Greeneville’s 23-yard line. If they converted ...

Eli Lilly anticipates regulatory approval for its weight-loss drug Zepbound in Japan by mid-2025, boosting its global portfolio If Medicare were to start covering popular weight loss drugs such as ...